Loading clinical trials...
Loading clinical trials...
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device (CES) for the treatment of insomnia characterized by difficulties with sleep maintenance using a 20-minute treatment right before bedtime.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
Yes
ProofPilot (Remote Virtual Trial)
New York, New York, United States
Start Date
October 1, 2020
Primary Completion Date
January 31, 2021
Completion Date
February 21, 2021
Last Updated
January 14, 2021
200
ESTIMATED participants
Fisher Wallace Neurostimulation Device
DEVICE
Lead Sponsor
ProofPilot
Collaborators
NCT06430957
NCT01778504
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions